期刊文献+

新疆汉族房颤患者GGCX基因rs11676382多态性及其与华法林稳定剂量相关性研究 被引量:4

GGCX Gene Polymorphism and the Relationship on Warfarin Stable Dosage in Xinjiang Han Nationality
原文传递
导出
摘要 目的研究新疆地区汉族房颤患者GGCX基因rs11676382位点多态性及其与华法林稳定剂量的相关性。方法从长居新疆地区的汉族房颤患者中,收集200例获得华法林稳定剂量的病例资料,所有入选者均采集外周血提取基因组DNA,采用聚合酶链反应,限制性片段长度多态性技术(PCR-RF凹)检查患者GGCX基因您11676382多态性的分布。比较不同基因型受试者之间华法林用量的差异。结果200例受试者中,GGCX基因阳11676382位点CC、CG和GG基因型的例数分别为150例(82.5%)、48例(16.5%)和2例(1.0%);C和G等位基因的频率分别为99%、1%;所选人群GGCX(rs11676382)等位基因频率和基因型频率均符合HaZy—Weinberg平衡(x^2=0.744,P=0.388),本组受试者稳定剂量范围是1.25,6.88mg/d,平均(3.22±1.12)mg/d。基因型为CC、CG和GG的受试者华法林稳定剂量分别为(5.93±1.33)mg/d、(3.22±0.88)mg/d和(3.16±1.40)mg/d。经秩和检验分析,GGCX(M11676382)多态位点与华法林稳定剂量显著相关(x^2=6.094,P=0.047)。结论获得了长居新疆地区汉族房颤患者的GGCX基因巧11676382多态性。同时发现基因型CC与高剂量相关,GG与低剂量相关,该位点可作为预测个体华法林稳定剂量的一项指标。 Objective In order to study if The Correlation between GGCX gene polymorphism and the relationship on warfarin stable dosage in Xinjiang han nationality with atrial fibrillation (Atrial Fibrillation AF) . Methods The blood was collected from 200 han nationality people who live in Xinjiang for long time and have atrial fibrillation, DNA was extracted, polymerase chain reac- tion-restriction enzyme fragment length polymorphism (PCR-RFLP) was used and identified by agarose eletrophoresis to analyse GGCX genotype and allele distribution. Results The result showed that GGCX gene CC, CG and GG gene type frequency we-re found respectively 82. 5 % , 16. 5 % and 1 % , and C and G allele frequency were 99 % , 1%. The GGCX (rs11676382) allele and genotype frequencies of selected crowd were the I-Iardy-Weinberg balance ( x^2=0. 744, P = 0. 388 ) . The subject on a stable dose range was 1. 25 -6. 88 mg/d, mean 3.22 ± 1.12 rag/d, The genotype of themwere CC: 5.93 ±1.33 mg/d, CG: 3.22 ±0.88 mg/d and GG: 3.16 ±1.14 mg/d. The Kruskal-Wallis test analysis : GGCX (rs11676382) polymorphisms were significantly associated with warfarin stable dose ( x^2 = 6. 094, P = 0. 047 ) . Conclusion Obtained GGCX gene rs11676382 polymorphism of xinjiang han patients with atrial fibrillation. The authors consider that warfarin high doses associated with genotype GGCX and low-dose-related. This can be used as an indicator to pre- dict an individual stable doses of warfarin.
出处 《医学分子生物学杂志》 CAS 2015年第4期202-206,共5页 Journal of Medical Molecular Biology
基金 基金项目:国家自然科学基金(No.81060017)
关键词 新疆 GGCX 汉族 心房纤颤 华法林 xinjiang GGCX Han nationality atrial fibrillatin warfarin
  • 相关文献

参考文献21

  • 1JIANGJ Q,SHEN F F ,FANG W Y ,et al. Novel GATA4 mutations in lone atrial fibrillation[J]. IntJ Mol Med, 2011 ,28( 6) : 1025-1032. 被引量:1
  • 2WU X, WANG L, WANG X, et al. Conserved DNA sequences discovered from atrial fibrillation related genes[J].Int HeartJ ,2011 ,52(5) :295-298. 被引量:1
  • 3CAO H, WANGJ , XI L, et al. Dysregulated atrial gene expression of osteoprotegerinl receptor activator of nuclear factor-KB( RANK)/RANK ligand axis in the development and progression of atrial fibrillation[J] . CircJ, 2011 ,75 (12) :2781-2788. 被引量:1
  • 4CHEN L,ZHANG W ,FANG C,et al. Polymorphism H558 R in the human cardiac Sodium Channel SCN5 A gene is associated with atrial fibrillation[J].J Int Med Res, 2011 ,39(5) :1908-1916. 被引量:1
  • 5SCOTT SA, PATEL M, MARTIS S, et al. Copy number variation and warfarin dosing: evalution of CYP2 C9, VKORCI , CVP4 F2, CGCX and CALU[J] , Pharmacogenomics,2011 ,13(3) :297-307. 被引量:1
  • 6MANN SA, OTWAY R, GUO G, et al. Epistatic effects of Potassium Channel variation on cardiac repolarization and atrial fibrillation risk[J].J Am Coll Cardiol, 2012 , 59 (11: 1017-1025. 被引量:1
  • 7向倩,王梓凝,谢秋芬,周颖,崔一民.房颤患者的华法林基因个体化治疗[J].中国临床药理学杂志,2014,30(1):43-44. 被引量:9
  • 8HUANG S W,CHEN H S,WANG X Q,et al,Validation of VKORCI and CYP2 C9 genotypes on interindividual warfarin maintenance dose: a prospectivestudy in Chinese patients[J] . Pharmacogenet Genomics, 2009 , 19 ( 3) : 226- 234. 被引量:1
  • 9EPSTEIN R S,MOYER T P,AUBERT R E,et aI, Warfarin genetyping reduces hospitalization rates results from the MM-WES(Medco-Mayo Warfarin Effectiveness study)[J].J Am Coll Cardiol ,2010 ,55 (25) :2804-2812. 被引量:1
  • 10KOHNKE H,SORLIN K,GRANATH G,et,al. Warfarin dose related to apolipoprotein E ( APOE ) genotype.[J] . EurJ Clin Pharmacol,2005,61 (5-6) :381-388. 被引量:1

二级参考文献61

  • 1许俊堂,胡大一.华法林的临床应用[J].中国医刊,2004,39(10):43-45. 被引量:63
  • 2杜宇奎,唐和年,张总刚.新疆维吾尔族健康人群维生素K环氧化物还原酶亚单位1启动子区1639A/G基因多态性研究[J].新疆医学,2007,37(1):14-16. 被引量:2
  • 3蒋年新,宋杰,徐标.维生素K环氧化物还原酶复合体1基因多态性对华法林维持剂量的影响[J].中华心血管病杂志,2007,35(7):652-654. 被引量:5
  • 4Rost S, Fregin A, Ivaskevicius V, et ak Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type-2[J]. Nature, 2004,427 (6974) : 537-541. 被引量:1
  • 5Veenstra DL, You JH, Rieder MJ, et al. Association of vitamin K epoxide reductase complex I(VKORC1) variants with warfarin close in a Hong Kong Chinese patient population[J]. Pharmacogenet Genomics, 2005,15 (10) : 687-691. 被引量:1
  • 6Schwarz UI, Ritchie MD, Bradford Y, et al. Genetic determinants of response to warfarin during initial anticoagulation[J].N Engl J Med, 2008,358(10) : 999-1008. 被引量:1
  • 7Bodin L, Verstuyft C, Tregouet DA, et al. Cytochrome P450 2C9(CYP2C9) and vitamin K epoxide reductase (VKORC1) genotypes as determinants of acenocoumarol sensitivity[J]. Blood, 2005,106 (1) : 135-140. 被引量:1
  • 8Schwarz UI, Ritchie MD, Yuki Bradford, et al. Genetic determinants of response to warfarin during initial anticoagulation [J]. N Engl J Med, 2008,358 (10): 999-1008. 被引量:1
  • 9Xie HG, Kin RB, Wood AJ, et al. Molecular basis of ethnic differences in drug disposition and response [J]. Annu Rev Pharmacol Toxicol, 2001,41 : 815-850. 被引量:1
  • 10Yuan HY, Chen JJ, Lee MT, et al.A novel functiona/VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity[J]. Hum Mol Genet, 2005,14 (13) : 1745-1751. 被引量:1

共引文献81

同被引文献40

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部